Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Active not recruiting 4Withdrawn 2Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 1Hypoxic Tumours 1Hypoxia 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × fluoroazomycin arabinoside × Clear all
NCT02496832 2018-02-19

A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

University Health Network, Toronto

Phase NA Withdrawn

Hypoxia, Neoplasm Metastasis

NCT00756691 2017-11-14

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

AHS Cancer Control Alberta

Withdrawn

Hypoxic Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡